tiprankstipranks
Trending News
More News >
Anika Therapeutics (ANIK)
NASDAQ:ANIK
US Market

Anika Therapeutics (ANIK) Income Statement

Compare
156 Followers

Anika Therapeutics Income Statement

Last quarter (Q4 2024), Anika Therapeutics's total revenue was $-1.29M, a decrease of -103.00% from the same quarter last year. In Q4, Anika Therapeutics's net income was $-21.86M. See Anika Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 119.91M$ 166.66M$ 156.24M$ 147.79M$ 130.46M
Gross Profit
$ 76.00M$ 103.09M$ 93.58M$ 82.94M$ 69.03M
Operating Expenses
$ 81.10M$ 191.47M$ 112.98M$ 101.42M$ 83.49M
Depreciation and Amortization
$ 0.00$ 14.22M$ 16.35M$ 15.99M$ 14.99M
EBITDA
$ -5.10M$ -11.23M$ -4.91M$ 2.62M$ -12.83M
Operating Income
$ -5.10M$ -87.64M$ -19.40M$ -18.48M$ -14.47M
Other Income/Expenses
$ 2.34M$ 2.31M$ 654.00K$ -188.00K$ -302.00K
Pretax Income
$ -2.76M$ -85.33M$ -18.75M$ 2.43M$ -28.62M
Net Income
$ -56.38M$ -82.67M$ -14.86M$ 4.13M$ -23.98M
Per Share Metrics
Basic EPS
$ -3.83$ -5.64$ -1.02$ 0.29$ -1.69
Diluted EPS
$ -3.83$ -5.64$ -1.02$ 0.28$ -1.69
Weighted Average Shares Outstanding
14.72M 14.66M 14.56M 14.40M 14.22M
Weighted Average Shares Outstanding (Diluted)
14.72M 14.66M 14.56M 14.63M 14.22M
Currency in USD

Anika Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis